✦ LIBER ✦

PMH5 COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS

✍ Scribed by Elkis, H; Pereira, M; Kayo, M; Duchesne, I; Alandete, JC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH21 THE COST-EFFECTIVENESS OF RISPERID

✍ J Damen; BMS Heeg; M Lothgren; BA Van Hout 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH23 COST-EFFECTIVENESS EVALUATION OF L

✍ N Edwards; M Rupnow; CL Pashos; MF Botteman; J Locklear; R Diamond 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH24 Cost of Long-Acting Risperidone In

✍ V. Omelyanovsky; M. Avxentyeva; O. Ivakhnenko; P. Khailov; F.M. Tsfasman; I. Kry 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost Effectiveness of Paliperidone Palmi

✍ Casallas, C.; Ariza, J.G. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PMH28 Using Cost-Effectiveness Analysis

✍ A. Valencia-Mendoza; A. Hernández-Garduño 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB